The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Time in the markets rather trying to time markets is a sound approach for most, anyone will do well to time this in the very short term :-)
Usually, if there's a buying spree (i honestly can't tell if there is one here as the sp is soooo messed up with silly tiny and huge trades) and it looks overbought i'll sell at least try and take advantage of a possible dip to get more shares for the same cash total. but, honestly, this is the first share i can remember in recent times that dropped significantly and then took back its value so slowly. i'm hoping this week sees TR1s that get it back over 1800. the higher it goes, the more tempted i'd be to sell (though 2200 does seem to be at least what one could anticpate in the coming weeks).
It's a cloud hanging over it and the 49.7% rise in profits can't have helped! But I share your optimism as all the CMA can do is require the sale of various veterinary practices in certain areas. Meanwhile, CVSG expands elsewhere. So, £30 by Xmas 2024?
Most commentators say it was an over-reaction and has been taken advantage of by mms or ii's. guess we'll see next week if we get the TR1s that show who thinks what about the current sp. But i seriously doubt it'll stay at this level for the nextsix months+.
but it's already up 20% from the low.
good weekend, all.
"and you have until early 2024 before worrying about CMA." Strange comment as the CMA is why the SP is currently where it is!
1640 and still moving... just more slowly than the usual junky AIM shares that herd buy into.
so, again... 1800 or 2000 or higher?
gla.
Nothing else to say about it, really.
maybe it's just that it doesn't do 40% in 30 minutes that keeps the herd away? But it's not as if others won't take them.
all is good.
CVS Group posted full-year results yesterday showing revenues up 9.8 per cent to £608.3 million and a 49.7 per cent increase in profit before tax to £53.9 million in the year to June 30.
Yesterday CVSG stock rose 101p, or 6.7 per cent, to £16.10, valuing the company at about £1.1 billion, and the final dividend was raised to 7.5p per share from 7p.
Fairman said CVS would support the regulator’s review and that it was “impossible to speculate on what the outcome may be”, but he was confident it would not hinder the company’s acquisitions in the meantime.
CVS has made three recent acquisitions and the regulator was sent briefing papers prior to the announcement of its review. “That is a very clear signal that we can continue to acquire in the UK,” Fairman said.
City analysts said the rerating in CVS’s share price had been “overdone” and believe that the sell-off has gone too far. Davy, the broker, said there appeared to be “little risk of price controls being introduced”.
https://www.thetimes.co.uk/article/cvs-group-defends-profit-margins-in-face-of-competition-inquiry-xr2l6b63x
Just seems to depend on how long you want to hold and how quickly the TR1s come through.
must be a relief to lthers that recovery looks very likely.
and you have until early 2024 before worrying about CMA.
gla.
CVS Group posted impressive Final Results for the year 30th June this morning. Revenue was up 9.8% to £608.3m, operating profit was up 45.6% to £62.3m, basic EPS was up 62.4% to £58.8m. Adjusted numbers were less stellar but still solid with adjusted EBITDA up 13% to £121.4m, adjusted EPS up 11.9% to 96p. The balance sheet remains solid despite the fact that Leverage increased to 0.73x as a result of the acquisition of Quality Pet Care Ltd. Net debt was up to £74m. Valuation is starting to look quite attractive with forward PE ratio at 15.9x, which is comfortably below the 23.6x trailing 12-month low for the share since FY17. The share price lacks positive momentum following its early September collapse following the Competition and Markets Authority launch of a review into the UK veterinary services market for household pets. CVSG remains a share to monitor for the time being, but company specific factors point to an increasingly attractive investment case...
...from WealthOracle
wealthoracle.co.uk/detailed-result-full/CVSG/804
Nm
Based on the market size, the fact the company has done most of it spending on expansion, making a healthy profit and paying a dividend, the MCAP should be in the £2b range.
Just the UK alone the Vet industry is worth over £2b a year.
If there's not a TR1 coming on who the seller is then this is just the new level (which i find hard to believe).
see what happens when BoD dip their toes again. If they thought that 1800 was cheap last couple of years then 1550 must see them shovelling the stuff.
Yes should make good progress once the bureaucratic scroungers have gone back to their kennels.
Https://twitter.com/surprised_trade/status/1704740468876059006
Profit before tax increased 49.7%, final dividend of 7.5p (+7%)
Everything is on track still.
Not too shabby when your profit before tax increases by 50%.
“Nope sorry, the last two had the same time’.
FFS , you need to buy a book on investing and understand what an actual UT is.
Nope, sorry. the last two had the same time... either a rolloever or a UT. but doesn't matter as not a lot anyone can do about it, now.
we'll see what's what at 0700. and then look for TR1s later.
No they weren’t, they were trades.
The ones you highlighted were, i think UTs...
CVS should take the CMA to court for destruction of share price value.
CMA had no basis to release the news, as the price rises are due to the macro inflation issues.
More than £500 million was wiped off the stock market value of a big veterinary company after regulators initiated a wide-ranging review of the sector.
The Times understands that the CMA assessed the announcement and deemed it not to be market-moving, largely because it had not yet made findings or used its formal powers. Yet shares in CVS Group fell by a third.
https://www.thetimes.co.uk/article/competition-review-leaves-veterinary-group-looking-poorly-bz67tj5nx